Country Bowls club teamed up with the Golfers from La Torre Golf Society to have a Bowls Pro-Am event in aid of our nominated ...

CARTAGENA has officially revived a military tradition with the return of the cañonazo (cannon salute) at the Arsenal Militar, ...

Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally ...

The COVER editorial team discuss the top stories in the first week of February 2025, including World Cancer Day, updates from a major network, new tools from the FCA and more.

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation follows ...

Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...

Y-mAbs is focused on advancing GD2-SADA and its PRIT platform to offer innovative cancer treatments, with ongoing clinical trials to refine the therapy's potential for broader patient use.